title: [Epigenetic therapy in myelodysplastic syndromes].
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Maki
authors.forename: Kinuko
authors.initials: K
authors.lastname: Mitani
mesh_terms: D001374:Azacitidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D047630:Depsipeptides / Q000008:administration & dosage*; D015195:Drug Design; D004359:Drug Therapy, Combination; D044127:Epigenesis, Genetic; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage*; D058990:Molecular Targeted Therapy; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics*; D016032:Randomized Controlled Trials as Topic; D000077337:Vorinostat
chemical_list: D047630:Depsipeptides; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat; D000077209:Decitabine; C087123:romidepsin; D015254:DNA Modification Methylases; D001374:Azacitidine